The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom
- 1 February 2012
- Vol. 30 (6) , 1225-1234
- https://doi.org/10.1016/j.vaccine.2011.11.026
Abstract
No abstract availableKeywords
Funding Information
- POLYMOD
- UK Department of Health Policy Research Programme (039/0031)
- ECDC
This publication has 30 references indexed in Scilit:
- Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in EnglandVaccine, 2011
- The Incidence and Clinical Characteristics of Herpes Zoster Among Children and Adolescents After Implementation of Varicella VaccinationThe Pediatric Infectious Disease Journal, 2009
- Varicella Prevention in the United States: A Review of Successes and ChallengesPediatrics, 2008
- Primary Vaccine Failure after 1 Dose of Varicella Vaccine in Healthy ChildrenThe Journal of Infectious Diseases, 2008
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious DiseasesPLoS Medicine, 2008
- Changing Varicella Epidemiology in Active Surveillance Sites—United States, 1995–2005The Journal of Infectious Diseases, 2008
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Epidemiology of varicella-zoster virus in England and WalesJournal of Medical Virology, 2003
- Economic Evaluations of Varicella Vaccination ProgrammesPharmacoEconomics, 2003
- Contacts with varicella or with children and protection against herpes zoster in adults: a case-control studyThe Lancet, 2002